Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Operating expenses:
Research and development	$ 7,445	$ 592
General and administrative	3,336	675
Total operating expenses	10,781	1,267
Loss from operations	(10,781)	(1,267)
Grant income	1,831	22
Other income (expense), net	84	(560)
Net loss	(8,866)	(1,805)
Unrealized (loss) on available-for-sale securities	(5)
Comprehensive loss attributable to common stockholders	$ (8,871)	$ (1,805)
Net loss per share attributable to common stockholders, basic and diluted	$ (0.25)	$ (0.48)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted	35,775,454	3,747,356